Linda B. Piller

4.7k total citations · 1 hit paper
54 papers, 2.2k citations indexed

About

Linda B. Piller is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Linda B. Piller has authored 54 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 12 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Surgery. Recurrent topics in Linda B. Piller's work include Blood Pressure and Hypertension Studies (20 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Heart Failure Treatment and Management (7 papers). Linda B. Piller is often cited by papers focused on Blood Pressure and Hypertension Studies (20 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Heart Failure Treatment and Management (7 papers). Linda B. Piller collaborates with scholars based in United States, Canada and Australia. Linda B. Piller's co-authors include Barry R. Davis, William C. Cushman, Jeffrey A. Cutler, Charles E. Ford, Jeffrey L. Probstfield, Chuke Nwachuku, Henry R. Black, Vasilios Papademetriou, Karen L. Margolis and Michael H. Alderman and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Linda B. Piller

52 papers receiving 2.1k citations

Hit Papers

Original Papers. Success and Predictors of Blood Pressure... 2002 2026 2010 2018 2002 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda B. Piller United States 21 1.4k 593 570 262 254 54 2.2k
Amit Kiran United Kingdom 16 1.8k 1.3× 464 0.8× 619 1.1× 282 1.1× 387 1.5× 26 3.0k
Jean‐Pierre Boissel France 22 1.7k 1.2× 458 0.8× 513 0.9× 244 0.9× 254 1.0× 53 2.9k
Mary T. Brophy United States 28 986 0.7× 478 0.8× 418 0.7× 436 1.7× 142 0.6× 114 3.3k
Ettore Ambrosioni Italy 28 2.6k 1.9× 654 1.1× 448 0.8× 189 0.7× 304 1.2× 117 3.2k
Adam P. Bress United States 26 1.5k 1.1× 386 0.7× 294 0.5× 155 0.6× 267 1.1× 130 2.5k
Vicente Bertoméu Spain 32 2.6k 1.9× 498 0.8× 891 1.6× 242 0.9× 150 0.6× 243 3.5k
Amanda H. Anderson United States 33 1.2k 0.9× 492 0.8× 448 0.8× 349 1.3× 407 1.6× 99 3.4k
Cassianne Robinson‐Cohen United States 38 666 0.5× 544 0.9× 672 1.2× 322 1.2× 422 1.7× 105 4.3k
Patricia R. Hebert United States 23 1.4k 1.0× 499 0.8× 900 1.6× 379 1.4× 294 1.2× 49 3.0k
Vassil Stoyanovsky United Kingdom 4 1.6k 1.2× 450 0.8× 268 0.5× 110 0.4× 371 1.5× 6 1.9k

Countries citing papers authored by Linda B. Piller

Since Specialization
Citations

This map shows the geographic impact of Linda B. Piller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda B. Piller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda B. Piller more than expected).

Fields of papers citing papers by Linda B. Piller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda B. Piller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda B. Piller. The network helps show where Linda B. Piller may publish in the future.

Co-authorship network of co-authors of Linda B. Piller

This figure shows the co-authorship network connecting the top 25 collaborators of Linda B. Piller. A scholar is included among the top collaborators of Linda B. Piller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda B. Piller. Linda B. Piller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aggarwal, Puja, Jhankruti Zaveri, Ryan P. Goepfert, et al.. (2019). Swallowing‐related outcomes associated with late lower cranial neuropathy in long‐term oropharyngeal cancer survivors: cross‐sectional survey analysis. Head & Neck. 41(11). 3880–3894. 20 indexed citations
2.
Sinha, A. K., Lemuel A. Moyé, Linda B. Piller, et al.. (2019). Adaptive group‐sequential design with population enrichment in phase 3 randomized controlled trials with two binary co‐primary endpoints. Statistics in Medicine. 38(21). 3985–3996. 7 indexed citations
3.
Han, Benjamin H., Jeff D. Williamson, Barry R. Davis, et al.. (2017). Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults. JAMA Internal Medicine. 177(7). 955–955. 120 indexed citations
4.
Haywood, L. Julian, Barry R. Davis, Linda B. Piller, et al.. (2017). Influence of Prevalent and Incident Atrial Fibrillation on Post-Trial Major Events in ALLHAT. Journal of the National Medical Association. 109(3). 172–181. 2 indexed citations
5.
Wallace, Susannah Kish, Nisha Rathi, D. Kim Waller, et al.. (2016). Two Decades of ICU Utilization and Hospital Outcomes in a Comprehensive Cancer Center. Critical Care Medicine. 44(5). 926–933. 26 indexed citations
6.
Wallace, Susannah Kish, D. Kim Waller, Barbara C. Tilley, et al.. (2015). Place of Death among Hospitalized Patients with Cancer at the End of Life. Journal of Palliative Medicine. 18(8). 667–676. 15 indexed citations
7.
Piller, Linda B., Lara M. Simpson, Sarah Baraniuk, et al.. (2014). Characteristics and Long-Term Follow-Up of Participants with Peripheral Arterial Disease During ALLHAT. Journal of General Internal Medicine. 29(11). 1475–1483. 24 indexed citations
8.
Waller, D. Kim, et al.. (2014). An evaluation of differences in risk factors for individual types of surgical site infections after colon surgery. Surgery. 156(5). 1253–1260. 47 indexed citations
9.
Luu, Hung N., E. Susan Amirian, R. Palmer Beasley, et al.. (2013). Clinical Implications of the Cervical Papanicolaou Test Results in the Management of Anal Warts in HIV-Infected Women. PLoS ONE. 8(11). e81751–e81751. 2 indexed citations
10.
Piller, Linda B., Jeff D. Williamson, Jeff Whittle, et al.. (2013). Risk of Hospitalized Gastrointestinal Bleeding in Persons Randomized to Diuretic, ACE‐Inhibitor, or Calcium‐Channel Blocker in ALLHAT. Journal of Clinical Hypertension. 15(11). 825–832. 8 indexed citations
11.
Rahman, Mahboob, Charles E. Ford, Jeffrey A. Cutler, et al.. (2012). Long-Term Renal and Cardiovascular Outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants by Baseline Estimated GFR. Clinical Journal of the American Society of Nephrology. 7(6). 989–1002. 54 indexed citations
12.
Barzilay, Joshua I., Barry R. Davis, Sara Pressel, et al.. (2012). Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension. Circulation Cardiovascular Quality and Outcomes. 5(2). 153–162. 48 indexed citations
13.
Baraniuk, Sarah, et al.. (2012). Comparison of the Global Statistical Test and Composite Outcome for Secondary Analyses of Multiple Coronary Heart Disease Outcomes. Progress in Cardiovascular Diseases. 54(4). 357–361. 3 indexed citations
14.
Ball, Greg, Linda B. Piller, & Michael H. Silverman. (2011). Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Contemporary Clinical Trials. 32. S2–S4. 13 indexed citations
15.
Bartholomew, L. Kay, William C. Cushman, Jeffrey A. Cutler, et al.. (2009). Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination Project. Clinical Trials. 6(4). 329–343. 15 indexed citations
16.
Einhorn, Paula T., Barry R. Davis, Barry M. Massie, et al.. (2006). The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) heart failure Validation Study: Diagnosis and prognosis. American Heart Journal. 153(1). 42–53. 45 indexed citations
17.
Piller, Linda B., Charles E. Ford, B. Davis, et al.. (2005). Angioedema in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). American Journal of Hypertension. 18(5). A92–A92. 1 indexed citations
18.
Papademetriou, Vasilios, Linda B. Piller, Charles E. Ford, et al.. (2003). Characteristics and Lipid Distribution of a Large, High‐Risk, Hypertensive Population: The Lipid‐Lowering Component of the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Journal of Clinical Hypertension. 5(6). 377–384. 13 indexed citations
19.
Cushman, William C., Charles E. Ford, Jeffrey A. Cutler, et al.. (2002). Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Journal of Clinical Hypertension. 4(6). 393–404. 742 indexed citations breakdown →
20.
Piller, Linda B., Barry R. Davis, Jeffrey A. Cutler, et al.. (2002). Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone. SHILAP Revista de lepidopterología. 3(1). 10–10. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026